A number of investment brokers have recently updated their price targets on shares of BioLife Solutions, Inc. (BLFS). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

02/01/2016 – Aegis Capital began new coverage on BioLife Solutions, Inc. giving the company a “buy” rating. They now have a USD 4 price target on the stock.

01/12/2015 – BioLife Solutions, Inc. had its “outperform” rating reiterated by analysts at Zacks. They now have a USD 8.5 price target on the stock.

07/23/2014 – Ladenburg Thalmann began new coverage on BioLife Solutions, Inc. giving the company a “buy” rating.

The share price of BioLife Solutions, Inc. (BLFS) was down -2.40% during the last day of trading, with a day high of 1.79. 11789 shares were traded during the last session.

The stock’s 50 day moving average is 1.83 and its 200 day moving average is 2.00. The stock’s market capitalization is 21.78M. BioLife Solutions, Inc. has a 52-week low of 1.51 and a 52-week high of 4.44.

View other investors thoughts on BioLife Solutions, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.